As of 2025-12-25, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 16.2x | 15.5x |
| Forward P/E multiples | 21.0x - 42.6x | 30.8x |
| Fair Price | (95.93) - (75.33) | (105.26) |
| Upside | -240.1% - -210.0% | -253.7% |
| Date | EV/EBITDA |